Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT03007147
Title Imatinib Mesylate and Combination Chemotherapy in Treating Patients With Newly Diagnosed Philadelphia Chromosome Positive Acute Lymphoblastic Leukemia
Recruitment Recruiting
Gender both
Phase Phase III
Variant Requirements No
Sponsors Children's Oncology Group
Indications

acute lymphoblastic leukemia

Therapies

Pegaspargase

Methotrexate

Leucovorin

Cytarabine

Mercaptopurine

Thioguanine

Vincristine Sulfate

Cyclophosphamide

Imatinib

Ifosfamide

Dexrazoxane

Daunorubicin

Dexamethasone

Methylprednisolone

Etoposide

Prednisolone

Doxorubicin

Age Groups: adult | child
Covered Countries USA | CAN


No variant requirements are available.